Navigation Links
Concentric Named Professional Agency of Record for Discovery Labs' SURFAXIN(R)
Date:9/3/2008

NEW YORK, Sept. 3 /PRNewswire/ -- Concentric Pharma Advertising, one of the fastest growing marketing agencies in the healthcare field, has been named agency of record by Discovery Labs for SURFAXIN(R) (lucinactant), an investigational drug being reviewed by the Food and Drug Administration for the treatment of respiratory distress syndrome (RDS) in newborns.

"We selected Concentric for this assignment because the company's strategic insight and creative vision best captured the essence of the SURFAXIN brand," said John Wilson, vice president of sales and marketing at Discovery, adding that the agency's in-depth knowledge of neonatology and acute RDS in premature infants also played a significant part in the decision.

The full-service U.S. assignment will include a wide range of activities, including corporate and product branding, positioning, and the creation of support materials geared to neonatologists, neonatal intensive care unit (NICU) nurses, respiratory therapists, hospital pharmacists, and, potentially, parents of newborns. The agency's account team will be led by Ed Mutch, account supervisor. Blake Benner, director of marketing at Discovery Labs, will manage the account on the client side.

Discovery Labs, headquartered in Warrington, Pa., is a biotechnology company developing novel surfactant replacement therapies (SRTs) with potential for application across the continuum of respiratory diseases, initially focusing on RDS in premature infants.

About Concentric

Concentric Pharma Advertising, an independent healthcare advertising and marketing firm established in 2002, is one of the fastest growing agencies in the healthcare field, enjoying double-digit revenue growth for the fourth year in a row. In the past year alone, the agency won 10 new assignments, launched a new division, expanded its senior management team, and won several awards in prestigious U.S. and global ad competitions.

Concentric offers a wide range of fully integrated marketing services, including professional and DTC advertising, corporate and product branding, sales force education, sales promotion, strategic and tactical planning, digital media, managed markets planning, formulary access programs, relationship marketing, and a full range of patient and consumer education programs. Clients include Alcon Labs, Bayer HealthCare, Cobalt Laboratories, Coria Laboratories, Discovery Labs, Mitsubishi Pharma USA, Neuromed, Pfizer and Wyeth.

Concentric is located at 71 West 23rd St, 9th floor, New York, NY 10010, but will soon be moving into spacious new quarters in lower Manhattan. To learn more, visit http://www.concentric-rx.com , call 212-633-9700, or email info@concentric-rx.com.

CONTACT: Julie Laitin (212) 286-2424 Cynthia Amorese (908) 665-8072

Email: jlaitin@julielaitin.com Email: camorese@comcast.net


'/>"/>
SOURCE Concentric Pharma Advertising
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
2. Concentric Wins Full-Service Professional Assignment From Biopharm Innovator Neuromed
3. Stoppert Named as President and CEO at Breakthrough Renewable Technology Firm Segetis, Inc
4. Baxa Corporation Named to Inc. 5000 for Second Consecutive Year as One of the Fastest-Growing Private Companies in the US
5. IDIS Opens New American Office in Response to Industrys Growing Need for Pre-Launch Named Patient Programs
6. Integrated Project Management Named to "Inc. 5000" for Second Year : One of the Top 100 Fastest-Growing Companies in Chicago Area
7. Bill Pollock, President and CEO of Pharmagistics Group, Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
8. CV Therapeutics Announces Ranexa(R) Named Finalist for Prix Galien USA 2008 Award
9. William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
10. Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
11. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 2017 , ... PMG Research is pleased to announce its participation ... Conference Forum in Boston on April 3-4, 2017. The CTC conference focuses on how ... and bring them closer to the patient. Clinical Trial Collaborations also will present an ...
(Date:3/27/2017)... DarioHealth Corp. (NASDAQ: DRIO), a leading global ... solutions, today announced that it is now offering a ... consumers who want to have their DarioHealth products reimbursed ... alliance agreements with partners across the U.S. who will ... approved, will supply and bill the customer,s insurance for ...
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... , March 24, 2017 On ... trading session at 5,817.69, down 0.07%; the Dow Jones ... and the S&P 500 closed at 2,345.96, marginally dropping ... sectors closed in green, 4 sectors finished in red, ... Friday, Stock-Callers.com has initiated reports coverage on the following ...
Breaking Biology Technology:
(Date:3/24/2017)... , March 24, 2017 The Controller General ... Controller Mr. Abdulla Algeen have received the prestigious international IAIR ... Continue Reading ... ... picture) and Deputy Controller Abdulla Algeen (small picture on the right) have ...
(Date:3/23/2017)... India , March 23, 2017 The report "Gesture ... Touchless Biometric), Industry, and Geography - Global Forecast to 2022", published by MarketsandMarkets, ... at a CAGR of 29.63% between 2017 and 2022. ... ... ...
(Date:3/22/2017)... , March 21, 2017   Neurotechnology , ... recognition technologies, today announced the release of the ... which provides improved facial recognition using up to ... a single computer. The new version uses deep ... accuracy, and it utilizes a Graphing Processing Unit ...
Breaking Biology News(10 mins):